135 related articles for article (PubMed ID: 16948697)
1. TCDD exposure-response analysis and risk assessment.
Cheng H; Aylward L; Beall C; Starr TB; Brunet RC; Carrier G; Delzell E
Risk Anal; 2006 Aug; 26(4):1059-71. PubMed ID: 16948697
[TBL] [Abstract][Full Text] [Related]
2. Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination.
Aylward LL; Brunet RC; Starr TB; Carrier G; Delzell E; Cheng H; Beall C
Risk Anal; 2005 Aug; 25(4):945-56. PubMed ID: 16268942
[TBL] [Abstract][Full Text] [Related]
3. Use of a toxicokinetic model in the analysis of cancer mortality in relation to the estimated absorbed dose of dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD).
Salvan A; Thomaseth K; Bortot P; Sartori N
Sci Total Environ; 2001 Jul; 274(1-3):21-35. PubMed ID: 11453298
[TBL] [Abstract][Full Text] [Related]
4. Caution in drawing conclusions from PBPK models based on sparse human data.
Steenland K; Bartell S
Risk Anal; 2007 Feb; 27(1):7-8; author reply 9-10. PubMed ID: 17362395
[No Abstract] [Full Text] [Related]
5. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example.
Heinzl H; Mittlböck M; Edler L
Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175
[TBL] [Abstract][Full Text] [Related]
6. Cause specific mortality and cancer incidence among employees exposed to 2,3,7,8-TCDD after a 1953 reactor accident.
Ott MG; Zober A
Occup Environ Med; 1996 Sep; 53(9):606-12. PubMed ID: 8882118
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study.
Steenland K; Deddens J; Piacitelli L
Am J Epidemiol; 2001 Sep; 154(5):451-8. PubMed ID: 11532787
[TBL] [Abstract][Full Text] [Related]
8. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Steenland K; Piacitelli L; Deddens J; Fingerhut M; Chang LI
J Natl Cancer Inst; 1999 May; 91(9):779-86. PubMed ID: 10328108
[TBL] [Abstract][Full Text] [Related]
9. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fingerhut MA; Halperin WE; Marlow DA; Piacitelli LA; Honchar PA; Sweeney MH; Greife AL; Dill PA; Steenland K; Suruda AJ
N Engl J Med; 1991 Jan; 324(4):212-8. PubMed ID: 1985242
[TBL] [Abstract][Full Text] [Related]
10. Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model.
Thomaseth K; Salvan A
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):743-53. PubMed ID: 9599726
[TBL] [Abstract][Full Text] [Related]
11. Cohort study of workers at a New Zealand agrochemical plant to assess the effect of dioxin exposure on mortality.
McBride DI; Collins JJ; Bender TJ; Bodner KM; Aylward LL
BMJ Open; 2018 Oct; 8(10):e019243. PubMed ID: 30337303
[TBL] [Abstract][Full Text] [Related]
12. Plasma dioxin levels and cause-specific mortality in an occupational cohort of workers exposed to chlorophenoxy herbicides, chlorophenols and contaminants.
Boers D; Portengen L; Turner WE; Bueno-de-Mesquita HB; Heederik D; Vermeulen R
Occup Environ Med; 2012 Feb; 69(2):113-8. PubMed ID: 21810927
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cancer risk assessment for dioxins using an occupational cohort.
Becher H; Steindorf K; Flesch-Janys D
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):663-70. PubMed ID: 9599714
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
Gaylor DW; Aylward LL
Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects on humoral immunity among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Saberi Hosnijeh F; Boers D; Portengen L; Bueno-de-Mesquita HB; Heederik D; Vermeulen R
Occup Environ Med; 2011 Jun; 68(6):419-24. PubMed ID: 21097950
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort.
Aylward LL; Brunet RC; Carrier G; Hays SM; Cushing CA; Needham LL; Patterson DG; Gerthoux PM; Brambilla P; Mocarelli P
J Expo Anal Environ Epidemiol; 2005 Jan; 15(1):51-65. PubMed ID: 15083163
[TBL] [Abstract][Full Text] [Related]
18. Uncertainty analysis in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) cancer dose-response for three occupational cohorts.
Dong Z; Yuan G; Hu J
Environ Int; 2016 Mar; 88():53-59. PubMed ID: 26708281
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
20. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
